Mumps arthritis
ICD-10 B26.85 is a billable code used to indicate a diagnosis of mumps arthritis.
Mumps arthritis is an inflammatory condition that occurs as a complication of mumps virus infection. The mumps virus, a member of the Paramyxoviridae family, primarily affects the salivary glands, but it can also lead to systemic complications, including arthritis. This condition is characterized by joint pain and swelling, typically affecting the knees, wrists, and ankles. The onset of arthritis usually occurs after the initial symptoms of mumps, such as fever, headache, and parotitis, have resolved. Diagnosis is primarily clinical, supported by serological tests that detect mumps-specific IgM antibodies or a rise in IgG titers. While mumps arthritis is generally self-limiting, symptomatic treatment may include nonsteroidal anti-inflammatory drugs (NSAIDs) to alleviate pain and inflammation. In rare cases, corticosteroids may be prescribed for severe symptoms. Vaccination against mumps is the most effective preventive measure, significantly reducing the incidence of the disease and its complications.
Detailed clinical notes on joint examination findings and serological test results.
Patients presenting with joint pain following a recent mumps infection.
Consideration of differential diagnoses such as reactive arthritis or other viral arthritides.
Comprehensive history of mumps exposure and vaccination status.
Patients with confirmed mumps infection presenting with joint symptoms.
Documentation of laboratory confirmation of mumps virus infection.
Used to confirm mumps infection in patients presenting with arthritis.
Document the reason for testing and the clinical findings leading to the test.
Infectious disease specialists should ensure comprehensive documentation of the patient's history.
Common symptoms include joint pain, swelling, and stiffness, typically affecting the knees, wrists, and ankles, occurring after the initial mumps infection.
